Related Experiment Video

Updated: Jun 3, 2026

Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

Probiotics and neonatal necrotizing enterocolitis

Erika C Claud1

  • 1Department of Pediatrics, Section of Neonatology, The University of Chicago, IL 60637, USA. eclaud@peds.bsd.uchicago.edu

Anaerobe
|March 8, 2011
PubMed

Insights

Probiotics may benefit preterm infants with necrotizing enterocolitis (NEC), but their effects on the developing gut microbiome and safety require further investigation. Understanding microbial colonization is key to NEC prevention in vulnerable infants.

Area of Science:

  • Neonatology
  • Microbiology
  • Gastroenterology

Background:

  • Necrotizing enterocolitis (NEC) is a significant concern in preterm infants.
  • Probiotics show potential benefits for NEC, but safety and efficacy are debated.
  • The developing gut microbiome plays a critical role in infant health.

Purpose of the Study:

  • To examine the impact of probiotics on the preterm infant gut microbiome.
  • To investigate the safety of probiotics in clinical trials for NEC.
  • To understand microbial colonization patterns in the neonatal intensive care unit (NICU) environment.

Main Methods:

  • Review of existing clinical trials on probiotics for NEC.
  • Analysis of studies on gut microbial colonization in preterm infants.
  • Assessment of factors influencing the preterm gut microbiome, including NICU interventions.

Main Results:

  • Probiotics demonstrate potential clinical benefits in reducing NEC incidence.
  • Concerns regarding probiotic safety and long-term effects persist.
  • The preterm gut microbiome is highly susceptible to environmental and iatrogenic influences.

Conclusions:

  • Further research is needed to clarify probiotic efficacy and safety in preterm neonates.
  • Understanding the complex interplay between the microbiome and NEC is crucial.
  • Optimizing microbial colonization may be a strategy for NEC prevention.

More Related Videos

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers09:36

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

Published on: July 28, 2022

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...